Stocks Health care MEHA

OTC · Health care

Functional Brands Inc. (MEHA)

Functional Brands Inc. brought in $6.7M of revenue over the twelve months to June 30, 2026. It posted a net loss of $8.5M. In fiscal 2025 capital spending exceeded operating cash flow by $1.3M. At June 30, 2026 it held $352.1K in cash against $138.7K of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Watch MEHA in 60 seconds

What Functional Brands Inc. does

Functional Brands Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker MEHA.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Full financial statements: income, balance sheet and cash flow

Where MEHA ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Functional Brands Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. August 17, 2026
   Quarterly results 8-K
2. August 14, 2026
   Quarterly report 10-Q · period to June 30, 2026Revenue rose 2.1% to $1.9M versus the same quarter last year; diluted EPS -$0.06 versus -$0.03.
3. July 13, 2026
   Delisting notice 25-NSE
4. July 2, 2026
   Executive or director change 8-K
5. July 1, 2026
   Material agreement ended 8-K
6. June 15, 2026
   Stock exchange listing notice 8-K
7. June 2, 2026
   Shareholder vote results 8-K
8. May 28, 2026
   Investor disclosure 8-K
9. May 27, 2026
   Additional proxy material DEFA14A
10. May 27, 2026
    Additional proxy material DEFA14A

Recent insider filings (Forms 3, 4 and 144): 3, the latest on May 20, 2026. Insider transactions on SEC

Who owns MEHA

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Latest filings below 5%: Helena Global Investment Opportunities 1 Ltd. 0% (May 19, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

We have not read this company's Form 4 filings yet.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about MEHA

What does Functional Brands Inc. do?

Functional Brands Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker MEHA.

Is Functional Brands Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $8.5M on revenue of $6.7M.

How much revenue does Functional Brands Inc. make?

Over the twelve months to June 30, 2026 Functional Brands Inc. reported revenue of $6.7M.

When did Functional Brands Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the quarterly results from August 17, 2026.

Similar companies

Compare MEHA with

Compare MEHA with any company

Follow MEHA

Get an email when Functional Brands Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow MEHA: get an email when it files

Where the numbers come from

Financial figures are the values Functional Brands Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.